Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05723562 |
Title | A Study of Dostarlimab in Untreated dMMR/MSI-H Locally Advanced Rectal Cancer (AZUR-1) |
Acronym | AZUR-1 |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | Yes |
Sponsors | GlaxoSmithKline |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | NLD | ITA | GBR | FRA | ESP | DEU | CAN |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
GSK Investigational Site | Little Rock | Arkansas | 72205 | United States | Details | |
GSK Investigational Site | Los Angeles | California | 90027 | United States | Details | |
GSK Investigational Site | Sacramento | California | 95817 | United States | Details | |
GSK Investigational Site | Whittier | California | 90602 | United States | Details | |
GSK Investigational Site | Washington | District of Columbia | 20010 | United States | Details | |
GSK Investigational Site | Atlanta | Georgia | 30322 | United States | Details | |
GSK Investigational Site | Chicago | Illinois | 60612 | United States | Details | |
GSK Investigational Site | Indianapolis | Indiana | 46237 | United States | Details | |
GSK Investigational Site | Baltimore | Maryland | 21215 | United States | Details | |
GSK Investigational Site | Boston | Massachusetts | 02215 | United States | Details | |
GSK Investigational Site | Detroit | Michigan | 48202 | United States | Details | |
GSK Investigational Site | Kansas City | Missouri | 64128 | United States | Details | |
GSK Investigational Site | Saint Louis | Missouri | 63110 | United States | Details | |
GSK Investigational Site | Albuquerque | New Mexico | 87131 | United States | Details | |
GSK Investigational Site | New York | New York | 10022 | United States | Details | |
GSK Investigational Site | Pittsburgh | Pennsylvania | 15232 | United States | Details | |
GSK Investigational Site | Sioux Falls | South Dakota | 57105 | United States | Details | |
GSK Investigational Site | Nashville | Tennessee | 37203 | United States | Details | |
GSK Investigational Site | Amarillo | Texas | 79106 | United States | Details | |
GSK Investigational Site | Dallas | Texas | 75390 | United States | Details | |
GSK Investigational Site | Richmond | Virginia | 23298 | United States | Details | |
GSK Investigational Site | Ottawa | Ontario | K1H 8L6 | Canada | Details | |
GSK Investigational Site | Toronto | Ontario | M5G 2M9 | Canada | Details | |
GSK Investigational Site | Montreal | Quebec | H2X 0A9 | Canada | Details | |
GSK Investigational Site | Sherbrooke | Quebec | J1H 5N4 | Canada | Details | |
GSK Investigational Site | BesanCon cedex | 25030 | France | Details | ||
GSK Investigational Site | Marseille | 13273 | France | Details | ||
GSK Investigational Site | Paris | 75012 | France | Details | ||
GSK Investigational Site | Pessac cedex | 33604 | France | Details | ||
GSK Investigational Site | Rennes | 35000 | France | Details | ||
GSK Investigational Site | Berlin | 13353 | Germany | Details | ||
GSK Investigational Site | Dresden | 01307 | Germany | Details | ||
GSK Investigational Site | Duesseldorf | 40225 | Germany | Details | ||
GSK Investigational Site | Frankfurt | 60488 | Germany | Details | ||
GSK Investigational Site | Muenchen | 81377 | Germany | Details | ||
GSK Investigational Site | Milano | 20133 | Italy | Details | ||
GSK Investigational Site | Padova | 35128 | Italy | Details | ||
GSK Investigational Site | Roma | 00168 | Italy | Details | ||
GSK Investigational Site | Chiba | 277-8577 | Japan | Details | ||
GSK Investigational Site | Kanagawa | 232-0024 | Japan | Details | ||
GSK Investigational Site | Osaka | 540-0006 | Japan | Details | ||
GSK Investigational Site | Osaka | 565-0871 | Japan | Details | ||
GSK Investigational Site | Seoul | 05505 | Korea, Republic of | Details | ||
GSK Investigational Site | Seoul | 06591 | Korea, Republic of | Details | ||
GSK Investigational Site | Seoul | 120-752 | Korea, Republic of | Details | ||
GSK Investigational Site | Seoul | 135-710 | Korea, Republic of | Details | ||
GSK Investigational Site | Utrecht | 3584 CX | Netherlands | Details | ||
GSK Investigational Site | Barcelona | 08035 | Spain | Details | ||
GSK Investigational Site | Granada | 18014 | Spain | Details | ||
GSK Investigational Site | Madrid | 28007 | Spain | Details | ||
GSK Investigational Site | Madrid | 28041 | Spain | Details | ||
GSK Investigational Site | Santander | 39008 | Spain | Details | ||
GSK Investigational Site | Valencia | 46010 | Spain | Details | ||
GSK Investigational Site | Leeds West Yorkshire | LS9 7TF | United Kingdom | Details | ||
GSK Investigational Site | London | EC1A 7BE | United Kingdom | Details | ||
GSK Investigational Site | Sutton | SM2 5PT | United Kingdom | Details |